-+ 0.00%
-+ 0.00%
-+ 0.00%

COYA THERAPEUTICS ANNOUNCES U.S. FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR COYA 302 FOR THE TREATMENT OF FRONTOTEMPORAL DEMENTIA (FTD)

路透·01/05/2026 13:00:06

登錄查看新聞詳情